-
PZ0369-5MG
PF-04217329 (C005B-432440)
Price: $253.46List Price: $281.62Biochem/physiol Actions PF-04217329 is a selective and potent prostaglandin EP2 receptor agonist. PF-04217329 is an ocular bioavailable isopropyl ester prodrug of CP-544326 (active acid metabolite). -
PZ0369-25MG
PF-04217329 (C005B-432441)
Price: $815.80List Price: $906.44Biochem/physiol Actions PF-04217329 is a selective and potent prostaglandin EP2 receptor agonist. PF-04217329 is an ocular bioavailable isopropyl ester prodrug of CP-544326 (active acid metabolite). -
P408101-1ml
PF-04691502 (C007B-247922)
Price: $350.69List Price: $389.66InformationPF-04691502 (PF4691502) is an ATP-competitivePI3K(α/β/δ/γ)/mTORdual inhibitor withKiof 1.8 nM/2.1 nM/1.6 nM/1.9 nM and 16 nM in cell-free assays, little activity against either Vps34, AKT, PDK1, p70S6K, MEK, ERK, p38, or JNK. PF-04691502 -
PZ0324-5MG
PF-06263276 (C005B-432518)
Price: $260.50List Price: $289.44Biochem/physiol Actions PF-06263276 is an inhibitor of the Janus kinase (JAK) enzymes 1, 2, 3 and tyrosine kinase 2 (TYK2). PF-06263276 has been investigated for the treatment of psoriasis. -
PZ0324-25MG
PF-06263276 (C005B-432519)
Price: $836.38List Price: $929.31Biochem/physiol Actions PF-06263276 is an inhibitor of the Janus kinase (JAK) enzymes 1, 2, 3 and tyrosine kinase 2 (TYK2). PF-06263276 has been investigated for the treatment of psoriasis. -
PZ0296-5MG
PF-06459988 (C005B-432566)
Price: $283.96List Price: $315.51Biochem/physiol Actions PF-06459988 is an orally available irreversible inhibitor of epidermal growth factor receptor (EGFR) mutant (EGFRm) forms including the secondary acquired resistance mutation T790M. PF-06459988 has minimal activity against -
PZ0296-25MG
PF-06459988 (C005B-432567)
Price: $692.31List Price: $769.23Biochem/physiol Actions PF-06459988 is an orally available irreversible inhibitor of epidermal growth factor receptor (EGFR) mutant (EGFRm) forms including the secondary acquired resistance mutation T790M. PF-06459988 has minimal activity against -
PZ0346-5MG
PF-06726304 ACETATE
Price: $274.58List Price: $305.08Biochem/physiol Actions PF-06726304 is a selective inhibitor of Histone-lysine N-methyltransferase EZH2 (enhancer of Zeste homolog 2), which catalyzes trimethylation of histone H3 lysine 27 (H3K27) and is amplified and/or overexpressed in several -
PZ0350-5MG
PF-06748962 (C005B-432470)
Price: $196.43List Price: $218.25Biochem/physiol Actions PF-06748962 is a potent and selective lactam-based prostaglandin EP3 receptor antagonist. Legal Information Sold for research purposes under agreement from Pfizer Inc. -
PZ0350-25MG
PF-06748962 (C005B-432471)
Price: $632.43List Price: $702.70Biochem/physiol Actions PF-06748962 is a potent and selective lactam-based prostaglandin EP3 receptor antagonist. Legal Information Sold for research purposes under agreement from Pfizer Inc. -
PZ0359-5MG
PF-06827443 (C005B-432456)
Price: $196.43List Price: $218.25Biochem/physiol Actions PF-06827443 is a otent, low clearance, orally bioavailable, and CNS penetrant muscarinic M1-selectivepositive allosteric modulator (PAM) with minimal agonist activity. Legal Information Sold for research purposes under -
PZ0359-25MG
PF-06827443 (C005B-432457)
Price: $632.43List Price: $702.70Biochem/physiol Actions PF-06827443 is a otent, low clearance, orally bioavailable, and CNS penetrant muscarinic M1-selectivepositive allosteric modulator (PAM) with minimal agonist activity. Legal Information Sold for research purposes under